Endocannabinoids are implicated in the control of glucose utilization and energy homeostasis by orchestrating pancreatic hormone release. Moreover, in some cell niches, endocannabinoids regulate cell proliferation, fate determination, and migration. Nevertheless, endocannabinoid contributions to the development of the endocrine pancreas remain unknown. Here, we show that α cells produce the endocannabinoid 2-arachidonoylglycerol (2-AG) in mouse fetuses and human pancreatic islets, which primes the recruitment of β cells by CB 1 cannabinoid receptor (CB 1 R) engagement. Using subtractive pharmacology, we extend these findings to anandamide, a promiscuous endocannabinoid/endovanilloid ligand, which impacts both the determination of islet size by cell proliferation and α/β cell sorting by differential activation of transient receptor potential cation channel subfamily V member 1 (TRPV1) and CB 1 Rs. Accordingly, genetic disruption of TRPV1 channels increases islet size whereas CB 1 R knockout augments cellular heterogeneity and favors insulin over glucagon release. Dietary enrichment in ω-3 fatty acids during pregnancy and lactation in mice, which permanently reduces endocannabinoid levels in the offspring, phenocopies CB 1 R −/− islet microstructure and improves coordinated hormone secretion. Overall, our data mechanistically link endocannabinoids to cell proliferation and sorting during pancreatic islet formation, as well as to life-long programming of hormonal determinants of glucose homeostasis.
cell adhesion | diabetes | G protein-coupled receptor | migration | proliferation A nandamide (AEA) and 2-arachydonoylglycerol (2-AG), major endocannabinoids (eCBs), are involved in the regulation of energy homeostasis through coordinated actions in peripheral organs (adipose tissue, liver, and pancreas) and brain (hypothalamus, ventral striatum) (1) . eCB signals are particularly significant to coordinate the regulated release of insulin and glucagon from mature pancreatic islets (2) (3) (4) (5) (6) . Genetic evidence from CB 1 cannabinoid receptor −/− (CB 1 R −/− ) mice supports these findings because CB 1 R −/− mice are lean, resistant to high fat diet-induced obesity and diabetes (4, (7) (8) (9) . Whether eCBs impact the formation of the endocrine pancreas and predispose it to long-lasting changes in hormone release postnatally remains unknown.
Because eCBs broadly affect cell proliferation, fate, motility, and differentiation (e.g., in sperm, hematopoietic and T cells, and neurons) (10) (11) (12) (13) , it is likely that they play a role in the cellular organization of developing pancreatic islets, possibly by affecting the spatial segregation of α and β cells. A contribution of eCBs to cell diversification and positioning in the developing pancreas is supported by the temporal control of their levels in fetal tissues (14) and circulation (15) . Moreover, α and β cells in mature pancreatic islets express the molecular machinery for eCB metabolism together with CB 1 Rs and transient receptor potential cation channels, particularly subfamily V member 1 (TRPV1) (2, 16, 17) . Understanding these developmental processes is also relevant to postnatal life because pancreatic α-and β-cell placement can be reconfigured upon metabolic demands in both rodents (18) and humans (19) , altering the efficacy of endocrine responsiveness.
Differential ligand and receptor recruitment within pleiotropic eCB signaling networks might facilitate a cellular context-and stage-dependent diversification of eCB signals. Thus, the coordinated availability of 2-AG and AEA and their varied action on CB 1 Rs (20) and TRPV1 channels (21) are well-positioned to orchestrate progenitor proliferation and the survival, migration, and ability of hormone secretion from ensuing differentiated cell lineages. Here, we demonstrate that paracrine 2-AG signaling determines cell segregation via CB 1 R-mediated adhesion signaling in the fetal mouse pancreas. In turn, chemical or genetic inactivation of TRPV1s on β cells increases cell proliferation both in vitro and in vivo, typically affecting the size of islets formed. Reducing eCB precursor bioavailability during pregnancy by ω-3 polyunsaturated fatty acid (PUFA) intake increases cellular heterogeneity and improves the temporal coordination of glucagon/ insulin release, phenocopying CB 1 R −/− mice, as well as human islets (19) . Cumulatively, our results outline a candidate mechanism for life-long cellular adaptation to metabolic challenges.
Results
Paracrine 2-AG Axis in the Fetal Pancreas. It is critical to document the cellular sites of eCB metabolism and receptor-mediated signaling to appreciate the abundance, cellular specificity, and modes of communication for these signaling lipids during the Significance Glucagon and insulin are produced in distinct cell populations within pancreatic Langerhans islets, where intercellular interactions control their production and release. Modifications to the microstructure of pancreatic islets are implicated in disease pathogenesis, but the developmental rules underlying cell commitment and segregation are incompletely understood. We show that endocannabinoids (ω-6) via CB 1 cannabinoid receptors and endovanilloid ligands via transient receptor potential cation channel subfamily V member 1, as well as dietary ω-3 polyunsaturated fatty acids, affect the cellular organization of pancreatic islets during organ development. Thus, lipid signaling emerges as a key determinant of tissue organization and can program hormone secretion for life.
formation of the endocrine pancreas, even more so because eCB signaling so far has been documented only in the fetal brain and musculature (10, 22) and has been shown to progress from a predominantly autocrine (prenatal) toward a paracrine (postnatal) mode of action (23) . Similar changes in the molecular configuration of eCB signaling in the fetal pancreas would have a notable impact on both reconstructing signaling events and interpreting functional outcome and disease relevance.
We used multiple immunofluorescence histochemistry to simultaneously detect CB 1 Rs and TRPV1s as eCB-sensing receptors (20, 21) , as well as sn-1-diacylglycerol lipase α (DAGLα), monoacylglycerol lipase (MAGL), and α/β hydrolase domaincontaining 6 serine hydrolase (ABHD6) (24) (defining minimal machinery for 2-AG metabolism), in mice at embryonic day (E) 16.5 ( Fig. 1 A-D1) , at birth, and in adulthood ( Fig. S1 and Tables S1 and S2). We refrained from dissecting the anatomy of AEA signaling because its biosynthetic machinery is incompletely understood (25) , precluding reliable microscale reconstruction. β, but not α, cells were CB 1 R-positive ( + ) at all developmental stages (P < 0.003 for all ranked data β vs. α cells) ( Fig. 1 A-A2 and E and Fig. S1 A-B2 ). In contrast, TRPV1 was present in both β and α cells at similar levels during pancreas development, as well as at maturity (Fig. 1 B-B2 and F and Fig. S1 C-E2) .
We found DAGLα preferentially expressed in α cells of the pancreatic primordium at E16.5 (P < 0.05 vs. β cells) ( Fig. 1 C-C2 and G), with its levels up-regulated in β cells at birth and throughout adulthood (Fig. S1 F-G2 ). MAGL expression was localized to α cells at all ages tested ( Fig. 1 D and H and Fig. S1 H, H1, and J-J3). Conversely, ABHD6 immunoreactivity in β cells exceeded that seen in α cells at all ages ( Fig. 1 D1 and I and Fig.  S1 I, I1, and K-K3). These data suggest that 2-AG signaling is paracrine first, with α cells being the source and β cells the sensors of 2-AG action (Fig. S1 L and M) . These results are compatible with the hypothesis that intercellular signaling modulates cell identity, mass, and migration during islet formation. In turn, mixed autocrine/paracrine signaling might be favored for cell survival.
Laboratory rodents present core-mantle islet morphology with an α cell mantle enwrapping its β cell-dense core (18) . In contrast, the organization of α and β cells in adult human pancreatic islets is remarkably different (Fig. 1J and SI Discussion) because these cell types remain predominantly interspersed (19) . This cellular configuration might be favored upon metabolic challenge because it Histochemical data from newborn and adult mice are shown in Fig. S2 . (E and F-I) Semiquantitative analysis of CB 1 R, TRPV1, DAGLα, MAGL, and ABHD6 immunosignals at successive developmental stages. Statistical comparisons were performed by nonparametric Wilcoxon's rank-sum test, n = 10 clusters or islets per group. Data are expressed as medians; ***P < 0.001, **P < 0.01, *P < 0.05. (J-L2) Glucagon could allow the improved coordination of insulin and glucagon release (26) . Nevertheless, CB 1 R and DAGLα distribution seem evolutionarily conserved and unrelated to cell positioning, inasmuch as CB 1 R and DAGLα strictly preferred β and α cells ( Fig. 1  K-L2) , respectively, even if at variable levels in the human biopsies available to us (SI Discussion).
Genetic Disruption of 2-AG Signaling Impairs Cell Segregation in Pancreatic Islets. If 2-AG signaling is significant in modulating pancreatic islet microstructure (that is, either the size of α and β cell pools or their spatial positions), then genetic disruption of 2-AG metabolism might impose permanent phenotypes. We have previously found that MAGL-mediated degradation is rate-limiting for fetal 2-AG signaling in brain (23) . Therefore, we first tested the analogous hypothesis by determining pancreatic islet morphology in adult MAGL −/− mice. Although the size of pancreatic islets remained unchanged (Fig. 2 A-B ) cells per section; P < 0.01] (Fig. 2C) . Because the number of β cells was unchanged ( (Fig. 2C2) .
Significantly, α cells were scattered within islet cores in MAGL
) vs. 0.14 ± 0.13 (MAGL +/+ ), P < 0.01, α cells in core per all α cells] (Fig. 2D) .
MAGL ablation-induced increased α cell mass and displacement can be due to the transdifferentiation, altered migration, survival, or proliferation of α cell precursors. Therefore, we mapped, in MAGL −/− islets, the expression of Pdx1 and MafA transcription factors that define β cell identity (27) and excluded their presence in glucagon + α cells ( Fig. 2 A and A1, Insets and Fig. S2 A-B2 ). This observation argues against transdifferentiation as a mechanism eliciting altered islet architecture in MAGL −/− mice. Because eCBs modulate cell migration and survival in the nervous system, adipose tissue, muscle, and immune system (13, 22, (28) (29) (30) (31) (32) , we instead favor that altered cell migration could, at least in part, contribute to incomplete cell segregation in MAGL −/− mice (Fig.  S3) . Loss of CB 1 R function due to receptor desensitization, characterized as CB 1 R pools being present intracellularly in MAGL −/− pancreas ( Fig. S2 C and D) , supports this hypothesis. Furthermore, the presence of the small GTPase Rac1 (Fig. S4 A-C1 ) and the microtubule-associated protein doublecortin (Fig. S4 D-I1 ) in β and α cells (33) presents downstream targets linked to cytoskeletal reorganization during cell migration (34, 35) . These findings are significant because both Rac1 and doublecortin expressions remain cell type-specific (Fig. S4 D-I ) and endure into adulthood.
2-AG Signaling Modulates β Cell Survival in Pancreatic Pseudobodies
in Vitro. Next, we tested 2-AG's effects on cell aggregation and survival in a model of ordered two-cell clustering (36) amenable to the in vitro chemical probing of signal transduction. αTC1-6 ("α-like") and INS-1E ("β-like") cells were mixed in suspension, producing ordered pseudobodies ("pseudoislets"), which resemble the murine pancreatic islet with an αTC1-6 cell mantle encapsulating a core made up of INS-1E cells (Movie S1). Although αTC1-6 and INS-1E cells are of mouse and rat origins, respectively, and their immortalized nature cautions data interpretation, they are still amenable for our purposes because (i) αTC1-6 cells express DAGLα but not CB 1 Rs, thus resembling α cells in vivo (Fig. S5) ; (ii) αTC1-6 cells contain and release significantly more 2-AG and AEA than INS-1E, recapitulating in vivo data on α cells being the primary source of eCBs ( We then determined whether either treatment modulates α or β cell numbers in individual pseudoislets in vitro. JZL184 did not affect the total number of αTC1-6 cells per pseudoislet (Fig. 2G) . Nevertheless, JZL184 significantly increased αTC1-6 "mixing," measured as αTC1-6 cells translocated to >10 μm depth from the surface in an OMDM188-sensitive manner [153 ± 35% (JZL184) vs. 100 ± 44% (control); F (3,36) = 3.25, P < 0.05] (Fig. 2G1) .
Subsequently, we showed that JZL184 increased αTC1-6 cell proliferation, as measured by Ki67 cytochemistry (40) (Fig. 2I and Fig. S7 A-B3). For INS-1E cells, DAGL inhibition was detrimental and reduced their numbers [F (3, 36) = 11.82, e.g., 21 ± 17 (OMDM188) vs. 99 ± 62 cells per cluster (control), P < 0.01] (Fig. 2H ) by promoting apoptosis (Fig. 2J ). These data suggest that 2-AG signaling is required for pseudoislet assembly and affects their size by limiting the survival of INS-1E cells. Moreover, augmentation of 2-AG signaling for ∼48 h impairs α/β-like cell segregation by misplacement of αTC1-6 cells, corroborating the MAGL −/− phenotype in vivo. Pseudoislets under control conditions preserved glucose-stimulated insulin (high glucose) and glucagon (low glucose) secretion ( Fig. S6 D and E) . As such, JZL184 pretreatment improved both insulin and glucagon release, and significantly increased the insulinto-glucagon ratio [0.30 ± 0.26 (JZL184) vs. 0.12 ± 0.05 ng/pg (control), F (3,8) = 4.12, P < 0.05 under peak insulin-permissive conditions] (Fig. S6F) . This increase was due to the continuously elevated release of insulin upon JZL184 application. In contrast, OMDM188 inhibited glucagon release in 2.75 mM glucose. In sum, 2-AG-induced incomplete cell segregation correlated with improved hormone release.
Altered Adhesion Signaling in MAGL
−/− Mice. Tissue architecture relies on how neighboring cells adhere to one another, which is mediated by anchoring systems that link in trans elements on partner cells and the extracellular matrix to the cell's cytoskeleton (41) . CB 1 R inhibition or desensitization disrupts adhesion signaling (2).
Here, we tested whether the subcellular distribution of E-cadherin (42) (Fig.  3F) . These results suggest altered cell-cell contacts as a molecular correlate of incomplete cell segregation.
CB 1 Rs Control Cell Sorting in Developing Pancreatic Islets. We hypothesize that eCBs act as positional signals for α and β cells (Fig. S3) . However, receptor heterogeneity exists because CB 1 R can be coexpressed with TRPV1 receptors in β cells. Therefore, we sought to address the specific contribution of CB 1 Rs and TRPV1s to the determination of islet size and cell segregation.
Our above data suggest that 2-AG, which acts at CB 1 R but not TRPV1 receptors (43) , possibly controls cell sorting in immature pancreatic islets. This notion prompted us to determine whether CB 1 R loss of function alters the microarchitecture of mouse pancreatic islets in vivo. The size of pancreatic islets from CB 1 R −/− mice remained unchanged ( expressed as means ± SD; n = 10 islets per genotype (D), n = 30 cells per genotype (E and F), n = 10 islets per group were analyzed in triplicate. ***P < 0.001, **P < 0.01, *P < 0.05 (Student's t test). cyto, cytoplasmic; membr, membraneous; perinuc, perinuclear.
( Fig. 4C) . The number of β cells (Fig. 4C1) was unaltered, thus positively skewing the α/β cell ratio [0.48 ± 0.16 (CB 1 R −/− ) vs. 0.33 ± 0.13 (CB 1 R +/+ ), P < 0.001] (Fig. 4C2) . Moreover, α cells were scattered within the islet core [0.21 ± 0.07 (CB 1 R −/− ) vs. 0.12 ± 0.08 (CB 1 R +/+ ), P < 0.001, α cells in core per all α cells] (Fig. 4D) . These results, and our data from MAGL −/− mice, raise the possibility that disrupted 2-AG signaling impairs cell segregation either due to dysfunctional (CB 1 R −/− ) or desensitized CB 1 Rs (MAGL −/− produce chronically and congenitally supraphysiological tissue 2-AG content, which internalizes CB 1 Rs in β cells) (Fig. S2 C and D) (7, 44) .
Next, we took advantage of pseudoislets as an in vitro model and used O-2050, a neutral CB 1 R antagonist (100 nM) (2) , to pharmacologically disrupt CB 1 R involvement in α/β cell sorting. O-2050 did not affect pseudoislet size (Fig. 4E and Fig. S8 A and  A1 (Fig. 4F ) and their mixing with β cells in pseudoislet cores (Fig. 4F1) . Subsequently, we exposed pseudoislets to AEA, a mixed eCB/endovanilloid ligand that acts as an agonist at both CB 1 Rs and TRPV1s (43) . AEA significantly increased pseudoislet diameter [13, (Fig. 4F ) but also led to incomplete cell sorting ( Fig. 4F1 and Fig. S8A2 ). Likewise, α and β cell mixing occurred when endogenously produced AEA was tested (URB597; 100 nM) ( Fig. S8 B-B3 ). However, AEA did not affect INS-1E cell recruitment to pseudoislets. If dual AEA effects are due to simultaneous signaling at CB 1 R and TRPV1 receptors, then coapplied O-2050 can be expected to reveal TRPV1-selective changes. Accordingly, AEA+O-2050 led to the segregation of α-and β-like cells into separate pseudoislets (>40% of pseudoislets contained one predominant cell type) (Fig. S8A3 ). This AEA effect was robust enough to positively bias our size measurements, leading to reduced sizes of single cell type-containing pseudoislets (Fig. 4G ). αTC1-6 cells do not express appreciable levels of CB 1 Rs (Fig.  S5) . Consequently, O-2050 did not affect either the rate of their proliferation or apoptosis (Fig. 4H and Fig. S7 C-D3) . AEA did not affect αTC1-6 cell proliferation or apoptosis either. In contrast, CB 1 R inhibition alone provoked the apoptosis of INS-1E cells [254 ± 26% (O-2050), F (3,10) = 23.12, P < 0.001], which was not antagonized by AEA coapplication (Fig. 4I and Fig. S7 D-D3) . AEA alone also triggered the apoptosis of INS-1E cells. Neither O-2050 nor AEA affected INS-1E cell proliferation significantly. These data suggest mutually exclusive roles for CB 1 R and TRPV1 in determining cellular heterogeneity in pancreatic islets.
TRPV1 Controls Pseudoislet Size. Both native α and β cells express TRPV1 receptors. Our data on AEA suggest that TRPV1 agonism can affect pancreatic islet size. This hypothesis is plausible also because Ca 2+ signaling (partly through TRPV1) is involved in regulating cell motility and adhesion (42) .
To dissect TRPV1 involvement in size determination, we analyzed the morphology of pancreatic islets from TRPV1 −/− mice ( (Fig. 5 C-C2) . Notably, the relative peripheral position of α cells within the islets was not affected (Fig. 5D ). Based on these results, we concluded that TRPV1 signaling could regulate the size of, but not cell segregation in pancreatic islets. We confirmed that TRPV1 activation is adverse for pseudoislet formation by using capsaicin (300 nM), a TRPV1 agonist [3,128 ± 654 (capsaicin) vs. 8,731 ± 1,997 μm 2 (control), F (3,184) = 26.67, P < 0.001] (Fig. 5E and Fig. S8 C and C1) . Conversely, capsazepine (10 μM), a TRPV1 antagonist (45) , significantly increased the size of the pseudoislets (38,423 ± 4,370, P < 0.001) (Fig. 5E and Fig. S8 C and C2) . Next, we confirmed these data using AMG 9810, an alternative TRPV1 antagonist (Fig. S8 D-D3 ), which also occluded the effect of capsaicin. Moreover, AEA at the concentration tested did not affect capsazepine (or AMG 9810) effects on islet size [50,751 ± 9,943 μm 2 (AEA + capsazepine), P < 0.001 vs. control] (Fig. 5E and Fig. S8 C and C3 ) but induced significant recruitment [61 ± 53 (AEA + capsazepine) vs. 17 ± 10 cells (control), F (3,36) = 3.61, P < 0.05] (Fig. 5F ) and mixing of αTC1-6 cells [185 ± 91% (AEA + capsazepine) vs. 100 ± 44% (control), F (3,36) = 3.75, P < 0.05] (Fig. 5F1) in the pseudoislets. These data clearly dissociate CB 1 R vs. TRPV1 outcome in the determination of islet microarchitecture.
Because TRPV1 antagonism alone did not affect the number of αTC1-6 cells in enlarged pseudoislets, we reasoned that an increased contingent of β cells might be recruited (or their survival affected). As Fig. 5G shows, quantitative morphometry confirmed this hypothesis [26 ± 16 (capsaicin), 171 ± 45 (capsazepine) and 230 ± 113 (AEA + capsazepine) vs. both P < 0.01 vs. 99 ± 62 (control) cell number per section, all F (3,36) = 16.42, P < 0.01 vs. control].
Lastly, we tested whether changes in αTC1-6 and INS-1E cell numbers in the pseudoislets were related to their altered rate of proliferation and/or apoptosis. Capsaicin remained ineffective in both cell types (Fig. 5 H and I) . Inhibition of TRPV1 signaling by capsazepine, however, significantly reduced the number of Ki67 + (proliferating) αTC1-6 cells [59 ± 40% (capsazepine) vs. 100 ± 15% (control), F (3,9) = 4.77, P < 0.05] (Fig. 5H and Fig. S7 E-E3 ) while being ineffective in altering the rate of αTC1-6 apoptosis ( Fig. 5H and Fig. S7 F-F3) . Notably, capsazepine also decreased INS-1E cell turnover [that is, a simultaneous decrease of the histological indices of apoptosis F (3,9) = 31.13 and proliferation F (3,9) = 21.43, both P < 0.05] (Fig. 5I and Fig. S7 E-F3 ). These data cumulatively suggest that TRPV1 is a key signaling node controlling pancreatic islet size.
Mixed Pancreatic Islets Favor Insulin over Glucagon Secretion. Increased dietary intake of ω-3 fatty acids is generally accepted to promote leanness by increasing adaptive hormone release from the endocrine pancreas (46, 47) . eCBs are derived from arachidonic acid (20:4) , an ω-6 PUFA. Correspondingly, ω-3 PUFAenriched diet during pregnancy lowers 2-AG and AEA levels in the fetus (48) . ω-3 PUFA intake is also beneficial for insulin secretion and sensitivity (49) (50) (51) . Here, we hypothesized that lowering eCB levels during pregnancy and lactation might be reflected in a mixed cell-pancreatic phenotype and improved hormonal responses to glucose in the offspring. We administered an ω3-PUFA-enriched diet to dams starting 3 months before pregnancy and through pregnancy and lactation (Fig. S9A ). Offspring were weaned onto normal laboratory chow and analyzed when reaching adulthood.
Maternal feeding with an ω3-PUFA-enriched diet resulted in reduced AEA levels in the blood of offspring weaned from ω3-fed mothers [5.20 ± 2.96 (ω3-PUFAs) vs. 24.70 ± 5.06 pmol/mg of lipids (control), P < 0.01] (Fig. 6A) . Dietary intake of ω3-PUFAs did not change the size of pancreatic islets (Fig. 6 B-C) or the absolute numbers of α or β cells (Fig. 6 C1 and C2) . Interestingly, ω3-PUFAs significantly increased the number of α cells scattered in the islet core [0.28 ± 0.13 (ω3-PUFAs) vs. 0.11 ± 0.09 (control), P < 0.05] (Fig. 6C3) . We then confirmed ω3-PUFA involvement by applying docosahexaenoic acid (DHA) (10 μM) to pseudoislets in vitro. DHA increased the size of pseudoislets [180 ± 55 (DHA) vs. 126 ± 29 (control), P < 0.05] (Fig. 6 D-D2) , as well as increased the number of αTC1-6 cells within pseudoislet cores [163 ± 56% (DHA) vs. 100 ± 46% (control), P < 0.05] (Fig. 6D3) , recapitulating eCB depletion. By performing a glucose tolerance test (GTT), we show that blood glucose levels were lower in mice that were characterized by a "mixed" islet phenotype [185.7 ± 28.7 (ω3-PUFA) vs. 231.0 ± 37.5 mg/dL (control), P < 0.05, 30 min after glucose injection; area-under-curve, 85 ± 7% of controls] (Fig. 6E) . In pancreatic islets isolated from these mice, insulin release in response to high glucose was unchanged (Fig. S9B) . In contrast, glucagon secretion was significantly inhibited in ω3-PUFA-fed mice in response to 2.75 mM glucose (Fig. 6F) . These changes, when analyzed as an insulin/glucagon ratio, led to a significant shift toward insulin signaling upon stimulation with 16.5 mM glucose [15 min: 0.15 ± 0.03 (ω3-PUFA) vs. 0.08 ± 0.01 ng/pg (control); 20 min: 0.29 ± 0.04 (ω3-PUFA) vs. 0.20 ± 0.05 ng/pg (control), both P < 0.05] (Fig. 6F1) . These data suggest that restricting eCB signaling in utero through dietary modulation of precursor availability might be beneficial for pancreatic functions.
Lastly, we assessed whether morphological phenocopy of pancreatic islets from CB 1 R −/− mice produces similar functional outcomes. GTT showed slower decrease in blood glucose in CB 1 (Fig. S9E ) with no change in glucagon secretion (Fig. S9E1) . This difference manifested as an increased insulin/glucagon ratio upon stimulation with 16 (Fig. S9E2) . Acute CB 1 R antagonism reduces insulin release in adult (53) . Perinatal CB 1 R (in-)activity might instead be beneficial by repositioning cell contingents to improve hormonal coupling. Together, these data suggest that the secretory responsiveness of α and β cells is significantly enhanced by the architectural heterogeneity of pancreatic islets.
Discussion
The present study suggests that paracrine eCB signals are present early in pancreas development in vivo. Even though we are aware of potential limitations of constitutive (vs. inducible) knock-out models, their combination with in vitro pharmacology can sufficiently support the differential engagement of CB 1 R and/or TPRV1 receptors to determine the pool size and microtopology of α and β cells in pancreatic islets (Fig. S3) . CB 1 R and TRPV1s are expressed during postnatal life, and the reconfiguration of pancreatic islets is an "on-demand" mechanism driven by metabolic challenges. Thus, tissue-derived and circulating 2-AG and AEA might bring about critically distinct islet phenotypes associated with or predisposing to metabolic hindrances or disease conditions.
Our secretion assays suggest that the microarchitecture of pancreatic islets is a primary determinant of coordinated insulin and glucagon secretion, with mixed islet phenotypes in rodents being superior to the regular "core-mantle" arrangements. This observation is significant because pancreatic islet morphology is evolutionarily varied (18) , reflective of the lifestyle, energy expenditure, and body mass of vertebrate species. As such, mixed pancreatic islets are characteristic of humans and nonhuman primates (18, 19) and suggest an evolutionary selection toward an anatomical microstructure that supports the increased dynamics of hormonal responses, especially in the presence of nutrient abundance. In rodents, reorganization of the core-mantle morphology of pancreatic islets, often interpreted as inadequate, might in fact Instead, the number of αTC1-6 cells residing in the psudoislet core was significantly increased. (E) Mice prenatally exposed to ω3-PUFAs showed improved glucose tolerance (n > 6 per group). (F) In primary mouse islets isolated from ω3-PUFA-fed mice, basal release of glucagon was decreased. (F1) Moreover, the correlated insulin/glucagon ratio was significantly increased upon high glucose. n ≥ 3 animals per group were quantitatively assessed. Data are expressed as means ± SD; n = 30 islets per group or n = 10 pseudoislets per group from triplicate experiments, **P < 0.01, *P < 0.05 [Student's t test (A-D3) or pairwise comparisons after one-way ANOVA].
confer adaptation to metabolic or pathogenic challenges. Accordingly, mixed pancreatic islet phenotypes have been associated with both physiological (i.e., pregnancy) (19) and pathophysiological (i.e., obesity, diabetes) (54, 55) conditions impacting glucose sensing and hormone secretion. Thus, we identify eCBs as a signaling network whose ligand diversity in conjunction with the receptor repertoire expressed by α and β cells is poised to tune hormone responsiveness. eCB signaling has been linked to the molecular control of insulin and glucagon release (2) (3) (4) . Considering that both CB 1 R −/− and MAGL −/− mice are lean (7, 8) , we suggest that their mixed pancreatic islets allow for improved short-range insulin signaling between α and β cells ("histoarchitectural gain of function"), which can serve as a feedback mechanism increasing the ratio of insulin to glucagon secretion under high glucose availability. This hypothesis is also supported by genetic data upon conditional insulin receptor knockout in α cells (56) , which induces hyperglucagonemia and glucose intolerance. Nevertheless, islet morphologies of adult CB 1 R −/− and MAGL −/− mice might represent either the outcome of developmental mechanisms or use-dependent and transient postnatal reorganization. The latter arrangement is particularly relevant in MAGL −/− mice because MAGL deletion affects not only 2-AG contents but also arachidonate precursor pools for prostaglandin synthesis (57), diversifying phenotypic outcome and cellular composition (e.g., macrophage infiltration) (58) . Our ω3-PUFA enrichment during embryonic and neonatal development and the ensuing incomplete α/β cell sorting phenotype suggest that reduced eCB bioavailability and signaling in utero (48) generate pancreatic islets mimicking CB 1 R −/− or MAGL −/− phenotypes. Implicating eCBs in these processes is appealing because mouse β cells lack GPR120, a "ω3-PUFA receptor" (59) (SI Discussion).
AEA and 2-AG exhibit remarkably different receptor specificities: Whereas both 2-AG and AEA bind CB 1 /CB 2 cannabinoid receptors, only AEA activates TRPV1 channels (43, 60) . We took advantage of this receptor selectivity when combining an in vitro model of ordered α-and β-cell aggregation with mouse genetics. This approach allowed us to dissect the ligand and receptor specificity of eCB signaling in relation to cell sorting and the control of pancreatic pseudoislet size. Thus, CB 1 R antagonism by O-2050 or indirectly by inhibiting DAGL-dependent 2-AG biosynthesis increased pseudoislet heterogeneity, identifying CB 1 Rs as a critical signaling node for regulating the spatial organization of α and β cells. Notably, OMDM188 eliminated β-cell recruitment to pseudoislets in vitro and enhanced β-cell death whereas both O-2050 and OMDM188 remained ineffective on α-cell proliferation or survival. These results are concordant with our receptor profiling of αTC1-6 and INS-1E cells (2) that suggested the lack of CB 1 R expression in αTC1-6 cells. Moreover, pancreatic islet morphology in MAGL −/− and CB 1 R −/− mice, where α cells venture extensively into the islet core, supports that both genetic deletion (CB 1 R −/− ) and desensitization (MAGL -/ ) of CB 1 Rs (7, 44, 61) inhibit the acquiring of prototypic cellular topography in the murine endocrine pancreas, which we consider as gain of function.
Another key finding of the present report is that TRPV1 agonism decreases whereas antagonism and genetic ablation increase the size of (pseudo)islets (62) without affecting spatial arrangements of α and β cells. Our developmental profiling and in vitro models suggest that TRPV1 signaling in pancreatic islets is independent of pancreatic innervation and relies on AEA as endogenous ligand. Chemical probing of TRPV1s selectively affected β-cell recruitment, and TRPV1 antagonism slowed cell proliferation. Therefore, we hypothesize that TRPV1 signaling is particularly efficacious to regulate the formation of cell-cell contacts underpinning cell aggregation. This finding is not entirely unexpected because previous data implicate signaling at TRPV1s in the proliferation of neural precursors, adipocytes, smooth muscle cells, and keratinocytes (63) (64) (65) (66) . In addition, the mobilization and aggregation of α and β cells is Ca 2+ -dependent (42), consistent with a TRPV1-mediated Ca 2+ influx in pancreatic β cells (45) . Therefore, it is tempting to speculate that activation of ligand-or voltage-gated Ca 2+ -permeable channels other than TRPV1 would recapitulate this prototypic TRPV1 response and could represent druggable targets to ameliorate β-cell dysfunction in diabetes.
Reorganization of pancreatic islet architecture can result from cell transdifferentiation, altered proliferation, survival, or migration related to remodeled cell-cell contacts (27, 67) . Transdifferentiation is unlikely to confound our experiments because both α and β cells retained their lineage identities as suggested by the selective presence of Pdx1 and MafA transcription factors in β cells, and glucagon expression restricted to α cells (27, 68) . This observation suggests that an eCB-mediated multicomponent mechanism operates during islet development: (i) 2-AG-induced CB 1 R activity is a survival signal for β but not α cells and supports the increased α/β cell ratio in (pseudo)islets when CB 1 R are inhibited; (ii) eCBs control cell turnover of both cell types; this suggestion is not surprising because eCBs regulate the proliferation of neural progenitors, adipocytes, and myoblasts (22, 69, 70) ; and (iii) eCBs affect cell motility and adhesion signaling.
We suggest that 2-AG signals can reorganize subcellular E-cadherin localization, with opposite outcomes in α and β cells. We propose that increased E-cadherin expression in α cells dispersed in islet cores is for the ectopic anchoring of resident β cells (67) , and allows in trans signaling for coordinated hormone secretion. Our E-cadherin data also support the hypothesis that active cell migration participates in mixed islet configuration (67) . As such, CB 1 R activation by both eCBs and synthetic agonists promotes the long-distance migration of neuroblasts and endothelial cells (29, 30) . Moreover, CB 1 Rs can signal through small GTPases, including RhoA and Rac1 in neurons (10), thus critically tuning cytoskeletal instability during neuronal morphogenesis and polarization. Our finding that Rac1 is expressed by both α and β cells and that Rac1 is crucial for pancreatic morphogenesis (35) identifies cell migration as a candidate mechanism for core-mantle cell sorting. This notion is further underscored by high doublecortin expression in α cells scattered in islet cores because doublecortin is a ubiquitous marker of cell motility during fetal organogenesis.
The endocrine pancreas is indispensable for adequately orchestrated insulin and glucagon release to maintain the body's energy homeostasis (1, 71) and to protect it from noxious metabolic stress (72) (73) (74) . Our knockout analysis focused on adult animals because both CB 1 R −/− and MAGL −/− mice are lean (7, 8, 52 ) and resistant to high-fat diet-induced obesity or diabetes (4, (7) (8) (9) . Although unchanged basal blood glucose and insulin levels of CB 1 R −/− and MAGL −/− mice were reported under standard feeding conditions (7, 52) , glucagon regulation-and particularly insulin/glucagon balance-in these mice remain unknown. We demonstrate slowed glucose clearance in young CB 1 R −/− mice, which is corroborated by recent data (9) . Our mechanistic analysis suggests that this profile rather reflects the decreased glucose need of peripheral tissues than any metabolic impairment because (i) both fasting (baseline) and terminal glucose levels are unchanged, (ii) CB 1 R −/− mice exhibit reduced muscle and adipose tissue mass (8), (iii) CB 1 R −/− mice respond properly to insulin challenge, and (iv) in islets isolated from CB 1 R −/− mice when islet dissection precludes the influence of tissue-derived or environmental confounds on glucose utilization, an improved relationship of insulin and glucagon secretion was observed. Likewise, we found improved insulin vs. glucagon secretion from morphologically similar pancreatic islets isolated from mice subjected to ω3-PUFA enrichment during fetal development. These data cumulatively link α cells infiltrating the core of pancreatic islets to enhanced α/β cell interplay and hormonal responsiveness. Therefore, we formulate the hypothesis that the increased number of α and β cell contacts drives paracrine signaling in the endocrine pancreas (19, 73) , possibly with insulin and glucagon secretion serving as a dual feedback mechanism for α and β cells, respectively (56, 75, 76) .
In conclusion, our report identifies fundamental roles for eCBs acting at CB 1 R and TRPVs in determining cellular diversity, structural complexity, and life-long plasticity of the endocrine pancreas.
We also highlight that maternal dietary choices during pregnancy can program fetal pancreas development by altering eCB bioavailability (48, 77) , which prospectively determines the offspring's sensitivity to metabolic stressors. This observation has clinicopathological significance by pointing to an increased risk of diabetes in either malnourished or obese mothers and underpins the clinical potential of tissue-selective regulation of eCB levels.
Experimental Procedures
Formation of α/β Cell Clusters, "Pseudoislets," in Vitro. INS-1E and αTC1-6 were cocultured at a 2:1 ratio in hybrid medium (10 mL) in 125-mL Erlenmeyer flasks under continuous agitation on gyrating shakers (70 rpm) at 37°C for 48 h (36). The microarchitecture of pseudoislets was analyzed by capturing serial orthogonal z-image stacks (2.5 μm optical thickness) by laser-scanning microscopy. The density and positions of αTC1-6 and INS1-E cells were calculated using ImageJ v1.45 with appropriate plug-ins. The core of each pseudoislet was defined as its volume >10 μm from the outer surface of the spherical structure.
Prenatal Exposure to ω3-Polyunsaturated Fatty Acid-Enriched Diet. Female C57Bl6/N mice (6 wk of age) were continuously fed with an experimental diet enriched in ω3-polyunsaturated fatty acids (21.42 kJ/g; 35% fat including 23.9% ω3 PUFA in the total diet, 25% crude protein, 40% carbohydrate; Special Diets Services) for 3 months before mating and during pregnancy and lactation. Pups were weaned on P21 and reared on a standard laboratory formulation. Control animals were exposed to a standard chow (energy, 15.38 kJ/g; 10% fat, 20% crude protein, 70% carbohydrate; Special Diets Services). Bodyweight of the offspring was measured every other day. At 6 wk of age, animals (n = 6 per group) underwent a glucose tolerance test (GTT) (SI Experimental Procedures) followed by the isolation of their pancreatic islets.
Statistics. Experiments were performed in triplicate unless stated otherwise. The Wilcoxon rank-sum test was used to analyze data on expression of the eCB system in pancreas during pre-and postnatal development after semiquantitative assessment with data presented as medians. Data from pharmacology experiments were analyzed using one-way ANOVA followed by pairwise comparisons. Student's t test (independent group design) was used to statistically evaluate data on pancreatic islet morphology and architecture in transgenic mice and after ω3-PUFA feeding. Data are expressed as means ± SD unless stated otherwise. Fold changes represent the percentage change from the untreated (control) value in individual experiments. A P < 0.05 value was considered statistically significant. A 3D rendering was used to qualitatively highlight cumulative changes in "eCB tone" during pancreas development.
Experiments on live animals conformed to the 86/609/EEC directive and were approved by the regional authority (Stockholm Norra Djuretiska Nämnd; N512/12). Ethical approval for use of human samples (Dnr: 00-128, Dnr 2010-279) was obtained from the Committee of Ethics, Faculty of Medicine, Uppsala University with informed consent from the individuals.
